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1. Introduction 
To our knowledge, uptake of lactate and pyruvate 
by the human kidney in vivo in normal subjects has 
not as yet been studied. These substrates are not taken 
up from the blood by the kidneys of patients afflicted 
with diabetes mellitus [I]. However, they are removed 
by the human kidney in vivo in certain other patho- 
logical states. This was first demonstrated in patients 
with various renal diseases [2] and, later observed [3] 
in obese patients following prolonged starvation. 
Since most of our knowledge concerning the metab- 
olism of lactate and pyruvate has been derived from 
arterio-venous measurements, the metabolic fate of 
these substrates in the human kidney remains uncer- 
tain. Complete oxidation of lactate was calculated [2] 
to account for 35% of renal oxygen consumption. 
However, it was concluded [3] that all the lactate and 
pyruvate carbon skeletons removed by the kidney 
were converted to glucose. 
In an attempt to clarify this subject, we studied 
the metabolism of lactate and pyruvate in isolated 
human kidney tubules. The data indicate that lactate 
and pyruvate may serve as the carbon sources of 
glucose and alanine in human kidneys, and that, at 
physiological concentration (1 mM), complete oxida- 
tion of lactate is very limited. 
2. Methods and materials 
2.1 . Isolation of human kidney tubules 
Fresh normal kidney cortex was obtained from the 
uninvolved pole of kidneys removed for neoplasm 
from 18 h fasted patients. Specimens of cortex were 
immediately dissected and placed in ice-cold Krebs- 
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Henseleit buffer [4] gassed with a mixture of 02-COz 
(95-5%) until the beginning of the isolation tech- 
nique-period (usually within 10 min). Kidney cortex 
tubules were isolated by the procedure in [5] as 
modified [6], with the exception that the concentra- 
tion of collagenase was increased 3-fold. 
2.2. Incubatioru 
Incubations were carried out at 37°C in a shaking 
water bath in 25 ml stoppered Erlenmeyer flasks in 
an atmosphere of 95% O,-5% COz. In all experi- 
ments, tubules were incubated in Krebs-Henseleit 
buffer in paired flasks containing lactate or pyruvate 
at equimolar concentrations (1 mM or 5 mM). The 
incubation volume was 4 ml, when substrate was 
1 mM. In order to increase the proportion of sub- 
strate removed by the tubules, the incubation volume 
was decreased to 2 ml when substrate was 5 mM. 
Reduction of the incubation volume from 4-2 ml did 
not affect the results obtained with 5 mM lactate or 
5 mM pyruvate, except that pyruvate accumulation 
from 5 mM lactate was reduced in the same propor- 
tion. Incubations were terminated by adding per- 
chloric acid (2% final cont.). In all experiments, zero- 
time flasks were prepared with and without substrates 
by adding perchloric acid before the tubules. After 
removing the denaturated protein by centrifugation, 
the supernatant was neutralized with 20% KOH for 
metabolite determinations. 
2.3. Analytical methods 
Lactate, pyruvate, glucose, alanine, aspartate, 
citrate, 2-oxoglutarate, fumarate, malate, glutamate, 
as well as the dry weight of the amount of tubules 
added to the flasks, were determined as in [6]. 
Ammonia was measured by the method in [7]. 
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2.4. CalculationLs lactate than has been cited [8] from 10 mM lactate. 
Net substrate utilization and product formation 
were calculated as the difference between the total 
flask contents at the start of the experiment and after 
the period of incubation. The metabolic rates are 
expressed in micromoles of substance removed or 
produced per gram dry weight of tubules per unit 
time. The results were analysed by the Student’s 
t test for paired data, comparing values obtained in 
the presence of lactate with those in the presence 
of an equimolecular concentration of pyruvate. The 
metabolic fates of lactate and pyruvate were estab- 
lished by calculating carbon balances. 
2 S. Chemicals 
L-lactate and pyruvate (sodium salts), enzymes. 
and coenzymes were from Boehringer Mannheim 
GmbH. Other chemicals were of analytical grade. 
At both substrate concentrations, the formation of 
glucose from lactate was significantly higher than that 
from pyruvate (fig.1); in this respect, human kidney 
resembles the dog kidney [6], but differs from the rat 
kidney in which pyruvate is a better gluconeogenic 
precursor than lactate [5,9-l 11. Such observations 
imply differences between species in the mechanism 
of glucose synthesis. Human kidney cortex [ 121, as 
well as dog kidney cortex [ 12,131, but not rat kidney 
cortex [ 121, contain both a cytosolic and a mito- 
chondrial phosphoenol pyruvate carboxykinase. As 
hypothesized for the dog kidney [6], WC believe that, 
in the human kidney, intramitochondrially formed 
phosphoenol pyruvate could contribute to the supply 
of carbon skeletons for gluconeogenesis, when lactate, 
but not pyruvate. is the substrate. Such an additional 
source of carbon skeletons for glucose synthesis from 
lactate could then explain why, in human and dog 
kidney, lactate is more gluconeogenic than pyruvate. 
3. Results and discussion 
3 .l . Time courses of the metabolism of lactate and 
pyruvate at low (I mM) and high (5 mM) concen- 
trations 
Tlie rates of lactate and pyruvate utilization were 
Figure 1 also shows that, despite an increased 
removal of substrates, glucose synthesis was not 
greater with 5 mM than with 1 mM lactate and pyru- 
vate; this indicates that the gluconeogenic pathway 
is already saturated with 1 mM substrate. 
virtually constant during 60 min incubation under all 
conditions (fig.1). In these in vitro experiments, as is 
the case under in vivo conditions [2], the utilization 
of lactate and pyruvate was found to increase, when 
the substrate concentration was raised. At equimolec- 
ular concentrations, the utilization of pyruvate was 
observed to be -2-times that of lactate. This was 
probably due to greater stimulation of pyruvate 
dehydrogenase and (or) pyruvate carboxylase by 
higher pyruvate concentrations when pyruvate was 
employed as the substrate. 
When lactate was the substrate, the accumulation 
of pyruvate was not found to be linear with time 
(fig.1). Pyruvate re-utilization was observed after 
45 min with 1 mM lactate, and after 15 min with 
5 mM lactate. Such kinetics clearly indicate that, in 
order for the lactate dehydrogenase reaction to reach 
near-equilibrium, the pyruvate concentration had to 
be adjusted to that of lactate according to the cqua- 
tion: 
[PYR] = K [LAC] [NAD+] /[NADH] [14] 
The rates of glucose synthesis from lactate and 
pyruvate were also constant with time (fig.]); this 
was also true without any substrate added. This 
linearity, as well as that of substrate utilization, 
clearly indicates that our human kidney tubules were 
metabolically active. On a wet weight basis (using a 
wet wt/dry wt ratio of 5.28 f 0.10, IZ = 16), it can be 
calculated that our tubules synthesized 7-8-times 
more glucose from 5 mM pyruvate than reported for 
human kidney tubules prepared [8]. Our tubules 
synthesized 4-5-times more glucose from 5 mM 
Lower pyruvate accumulation from 5 mM than from 
1 mM lactate was found to be due to the reduction of 
the medium volume from 4-2 ml with 5 mM lactate 
as substrate. 
When pyruvate was the substrate, the rate of lactate 
synthesis, was found to be constant with time (fig.1). 
This implies that the rate of transport of reducing 
equivalents in the form of malate [ 15,161 from the 
mitochondria to the cytosol was constant with time. 
No increase in lactate synthesis was observed 
when pyruvatc was used at 5 mM instead of 1 mM. 
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Fig. 1. The time courses of L-lactate and pyruvate metab- 
olism in isolated human kidney cortex tubules. Incubations 
occurred in Krebs-Henseleit medium, in the absence of added 
substrate (m) or in the presence of L-lactate (1 mM (0); 5 mM 
(o)), or in the presence of pyruvate (1 mM (A); 5 mM (A)). 
Each value represents the mean of 4 experiments (for 1 mM 
substrate) or 5 experiments (in the case of 5 mM substrate). 
Vertical lines represent + or - SEM. In the 1 mM substrate 
series, each flask contained 2.54 + 0.31 mg dry wt. tubules; 
in the 5 mM substrate series, each flask contained 
7.10 f 1.28 mg dry wt tubules. *P < 0.05, **P < 0.01 
(according to Student’s f-test for paired data). Time (min) 
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This indicates that, despite an increased availability of 
carbon skeletons for lactate synthesis, the supply of 
reducing equivalents from 5 mM pyruvate was not 
higher than that from 1 mM pyruvate. Thus, there are 
at least one, or perhaps several rate-limiting steps in 
the sequence of reactions involved in the supply of 
reducing equivalents to the cytosol; these may include 
pyruvate carboxylase, mitochondrial malate dehydro- 
genase, transport of malate across the mitochondrial 
membrane, or cytosolic malate dehydrogenase. 
The formation of alanine from lactate and pyru- 
vate (fig.1) is consistent with the demonstration of 
glutamate-pyruvate transaminase activity in the 
human kidney [ 171. As expected, the rate of alanine 
synthesis was higher from pyruvate than from lactate. 
Alanine synthesis raises the question of the origin of 
the alanine amino group. The production of ammonia 
observed in the absence of added substrate was 
reduced in the presence of lactate and, to a greater 
extent, in the presence of pyruvate. This indicates 
that amino acid nitrogens were incorporated into the 
alanine molecule (presumably by transamination of 
glutamate), instead of being released via the glutamate 
dehydrogenase reaction. In the presence of pyruvatc 
and lactate, and after 60 min, the utilization of gluta- 
mate, which was present at the start of the incubation 
period, could account for -33% and -2O%, respec- 
tively, of the alanine nitrogen found. Aspartate was 
neither found to be used nor produced in net amounts. 
Thus, other amino acids, which remain to be identi- 
fied, must have contributed to the alanine amino 
group. 
tubules 
Table 1 shows that, after 60 min, glucose was the 
main product of lactate metabolism at both 1 mM 
and 5 mM. This suggests that lactate may significantly 
contribute to the renal production of glucose, which 
occurs in patients with chronic obstructive airway 
diseases [IS] and in obese subjects undergoing pro- 
longed starvation [3]. Glucose synthesis from lactate 
might appear to be of no importance in patients with 
renal diseases, because the kidneys of these patients 
do not release glucose [2]. llowever, this does not 
necessarily mean that glucose is not an end-product 
of lactate metabolism in these patients; it is conceiv- 
able that glucose synthesis from lactate, occurring in 
the cortex, is balanced by glucose utilization in the 
medulla, which is believed to have a predominantly 
glycolytic metabolism [ 191. This view is supported 
by the recent demonstration [20] that, in vivo, the 
superficial cortex of cat kidney produces glucose in 
net amounts, whereas the deep cortex and the 
medulla take it up. 
Table 1 also shows that 20% of the lactate (1 mM) 
removed was accounted for by alanine. Thus, lactate 
appears to be a potential carbon source of the alanine 
which is added to renal venous blood by the human 
kidney [21]. 
It should be pointed out that the lactate ‘not 
accounted for’ represented a significant fraction of 
lactate metabolism (which was presumably completely 
oxidized in the tricarboxylic acid cycle) only at 5 mM 
(table 1). Althou’gh one should be cautious in extra- 
Table 1 
The fates of lactate and pyruvate carbon skeletons in isolated human kidney tubules 
___- 
Substrate added Products formed 
GIUCOX? 
(70) 
____ 
Pyruvate 
(%) 
Lactate 
(%) 
Alanine 
(‘/cl 
Not accounted 
for (c/n) 
1 mM L-lactate 56.6 15.4 _ 21.7 6.3 
1 mM Pyruvate 23.7 _ 34.3 15.0 27.0 
5 mM L-lactate 42.0 7.1 _ 14.3 36.6 
5 mM Pyruvate 18.7 26.4 14.3 40.6 
The values, which are derived from those of fig.1 are means. They are expressed in percen- 
tapes of the substrate removal. The calculations were made on the assumption that the 
added substrate are the sole sources of the products measured, and that t\vo lactate or 
pyruvate molecules are needed for the synthesis of each glucose molecule. No net forma- 
tion of citrate, 2-oxoglutarate, glutamate, fumarate and malatc was observed 
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polating in vitro results to the in vivo situation, this 
suggests that, at physiological concentration (1 mM), 
lactate does not supply energy for the renal reabsorp- 
tive work. 
Since the normal blood concentration of pyruvate 
is -0.1 mM, it is doubtful that pyruvate metabolism 
by the human kidney in vivo is of great physiological 
importance. The data of table 1 suggest, however, 
that, in situations where the blood pyruvate concen- 
tration is increased (e.g., in hyperlactatemia and lactic 
acidosis), pyruvate might become an important 
energy supplier of the human kidney. 
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